Overview of the diagnosis and treatment of autoimmune skin disorders in horses.

1. Rosenkrantz W. Immune-mediated dermatoses. Vet Clin North Am Equine Pract 2013;29:607–613.
   pubmed: 24267678
2. Olivry T, Linder KE. Dermatoses affecting desmosomes in animals: A mechanistic review of acantholytic blistering skin diseases. Vet Dermatol 2009;20:313–326.
   pubmed: 20178467
3. Pusterla N, Watson JL, Affolter VK, Magdesian KG, Wilson WD, Carlson GP. Purpura haemorrhagica in 53 horses. Vet Rec 2003;153:118–121.
   pubmed: 12918829
4. Vandenabeele SIJ, White SD, Affolter VK, Kass PH, Ihrke PJ. Pemphigus foliaceus in the horse: A retrospective study of 20 cases. Vet Dermatol 2004;15:381–388.
   pubmed: 15585014
5. Cappelli K, Brachelente C, Passamonti F, Flati A, Silvestrelli M, Capomaccio S. First report of junctional epidermolysis bullosa (JEB) in the Italian draft horse. BMC Vet Res 2015;11:55.
   pmc: PMC4372232pubmed: 25889423
6. Spirito F, Charlesworth A, Linder K, Ortonne JP, Baird J, Meneguzzi G. Animal models for skin blistering conditions: Absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse. J Invest Dermatol 2002;119:684–691.
   pubmed: 12230513
7. Scott DW, Miller WH. Equine Dermatology. 2nd ed. St. Louis, Missouri: Elsevier Saunders; 2011.
8. Zabel S, Mueller RS, Fieseler KV, Bettenay SV, Littlewood JD, Wagner R. Review of 15 cases of pemphigus foliaceus in horses and a survey of the literature. Vet Rec 2005;157:505–509.
   pubmed: 16244232
9. Craft WF, Marsella R, Rodrigues-Hoffmann A. Skin biopsy guidelines: Tips and advice from veterinary pathologists to practitioners. J Am Vet Med Assoc 2023;261(S1):S114–121.
   pubmed: 37037420
10. Sauvé F. Use of topical glucocorticoids in veterinary dermatology. Can Vet J 2019;60:785–788.
    pmc: PMC6563888pubmed: 31281200
11. Peroni DL, Stanley S, Kollias-Baker C, Robinson NE. Prednisone per os is likely to have limited efficacy in horses. Equine Vet J 2002;34:283–287.
    pubmed: 12108748
12. Leclere M. Corticosteroids and immune suppressive therapies in horses. Vet Clin North Am Equine Pract 2017;33:17–27.
    pubmed: 28325178
13. von Tscharner C, Yager J, Kunkle G. Immunologic diseases. Vet Dermatol 2000;11:163–178.
    pubmed: 0
14. Bailey SR. Corticosteroid-associated laminitis. Vet Clin North Am Equine Pract 2010;26:277–285.
    pubmed: 20699175
15. Bello K, Lorch G, Kim K. Pharmacokinetics and tolerability of multiple-day oral dosing of mycophenolate mofetil in healthy horses. J Vet Intern Med 2023;37:1907–1916.
    pmc: PMC10472989pubmed: 37469186
16. Visser M, Cleaver D, Cundiff B, King V, Sture G. Oclacitinib maleate (Apoquel) dose determination in horses with naturally occurring allergic dermatitis. 2020 ACVIM forum on demand research abstract program. J Vet Int Med 2020;34:2977–2978.
17. Hunyadi L, Datta P, Rewers-Felkins K. Pharmacokinetics of a single dose of oclacitinib maleate as a top dress in adult horses. J Vet Pharmacol Ther 2022;45:320–324.
    pubmed: 35098559
18. Marsella R, Doerr K, Gonzales A, Rosenkrantz W, Schissler J, White A. Oclacitinib 10 years later: Lessons learned and directions for the future. J Am Vet Med Assoc 2023;261(S1):S36–47.
    pubmed: 36944222
19. Nogradi N, Couetil LL, Messick J, Stochelski MA, Burgess JR. Omega-3 fatty acid supplementation provides an additional benefit to a low-dust diet in the management of horses with chronic lower airway inflammatory disease. J Vet Intern Med 2015;29:299–306.
    pmc: PMC4858086pubmed: 25307169

Citations